ARTICLE | Distillery Therapeutics
Hepatic
November 30, 2016 2:14 PM UTC
Patient sample and mouse studies suggest inhibiting WWTR1 could help treat NASH. In obese patients, WWTR1 levels were higher in liver samples from patients with NASH histology than from patients with ...
BCIQ Company Profiles
BCIQ Target Profiles
WW domain containing transcription regulator 1 (WWTR1) (TAZ)